{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:32Z","timestamp":1761895592819},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":9867,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1993]]},"DOI":"10.1093\/annonc\/4.suppl_1.s21","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T16:53:32Z","timestamp":1353344012000},"page":"S21-S27","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S1","title":["The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease"],"prefix":"10.1016","volume":"4","author":[{"given":"A.H.","family":"Goldstone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.V52.1.85.85","article-title":"Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma","volume":"52","author":"Appelbaum","year":"1978","journal-title":"Blood"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0010","first-page":"208","article-title":"Cryopreserved autologous bone marrow transplantation in the treatment of selected paediatric malignancies. A preliminary report","volume":"1","author":"Kaizer","year":"1979","journal-title":"Transplantation Proceedings"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0015","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1987.5.9.1340","article-title":"Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation and marrow transplantation","volume":"5","author":"Appelbaum","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7326\/0003-4819-104-2-163","article-title":"High dose Cyclophosphamide, Carmustine and Etoposide and ABMT for relapsed Hodgkin\u2019s disease","volume":"104","author":"Jagganath","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/bjc.1986.127","article-title":"High dose chemotherapy and ABMT in refractory Hodgkin\u2019s disease","volume":"53","author":"Philip","year":"1986","journal-title":"Brit J Cancer"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0030","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1200\/JCO.1988.6.9.1411","article-title":"High dose chemotherapy and autologous bone marrow transplantation in 50 advanced resistant Hodgkins disease patients: An Italian study group report","volume":"6","author":"Carella","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0035","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V73.1.340.340","article-title":"Successful treatment of refractory Hodgkins disease by high-dose combination chemotherapy and autologous bone marrow transplantation","volume":"73","author":"Gribben","year":"1989","journal-title":"Blood"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0040","series-title":"Recent advances in haematology","article-title":"The management of Hodgkin\u2019s disease and the non-Hodgkin\u2019s lymphomas","author":"Linch","year":"1988"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-104-6-739","article-title":"Alternating non-cross resistant combination chemotherapy or MOPP in stage IV Hodgkin\u2019s disease: A report of 8 year results","volume":"104","author":"Bonnadonna","year":"1986","journal-title":"Ann Int Med"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0050","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1992.10.8.1252","article-title":"LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin\u2019s disease: Results of a British National Lymphoma Investigation Trial","volume":"10","author":"Hancock","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0055","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of advanced Hodgkin\u2019s disease with MOPP, ABVD, or MOPP alternating with ABVD","volume":"327","author":"Canellos","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.1992.10.2.210","article-title":"Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin\u2019s disease after combination chemotherapy: the low probability for cure","volume":"10","author":"Longo","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.annonc.a057689","article-title":"Salvage chemotherapy in Hodgkin\u2019s disease. Results in patients relapsing more than twelve months after first complete remission","volume":"1","author":"Viviani","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.1992.10.2.200","article-title":"The optimal timing of autologous bone marrow transplantation in Hodgkin\u2019s disease patients after a chemotherapy relapse","volume":"10","author":"Desch","year":"1992","journal-title":"J Clin Oncol"},{"issue":"suppl 2","key":"10.1093\/annonc\/4.suppl_1.S21_bb0075","first-page":"23","article-title":"Third line salvage chemotherapy in Hodgkin\u2019s disease","volume":"12","author":"Bonnadonna","year":"1985","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1987.5.4.556","article-title":"MIME chemotherapy as treatment for recurrent Hodgkin\u2019s disease","volume":"5","author":"Hagemeister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mpo.2950180609","article-title":"Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin\u2019s disease: a CALGB study","volume":"18","author":"Schulman","year":"1990","journal-title":"Med Pediatr Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2141.1992.tb08207.x","article-title":"Mini-BEAM followed by BEAM and ABMT for very poor risk Hodgkin\u2019s disease","volume":"81","author":"Chopra","year":"1992","journal-title":"Brit J Haematol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0095","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.1992.10.7.1086","article-title":"High dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin\u2019s disease","volume":"10","author":"Tourani","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1990.8.3.527","article-title":"High dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin\u2019s disease","volume":"8","author":"Jones","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0105","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1200\/JCO.1991.9.10.1871","article-title":"Intensive chemotherapy with cyclophosphamide, carmustine and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin\u2019s disease","volume":"9","author":"Reece","year":"1991","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1093\/annonc\/4.suppl_1.S21_bb0110","first-page":"866","article-title":"High dose cyclophosphamide, carmustine, and etoposide (CBV) in 128 patients with Hodgkin\u2019s disease","volume":"72","author":"Bierman","year":"1988","journal-title":"Blood"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0115","unstructured":"Chopra R, McMillan A, Linch D et al. The place of high dose BEAM therapy and ABMT in poor risk Hodgkin\u2019s disease. A single centre eight year study of 155 patients. Blood (in press)"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0120","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/oxfordjournals.annonc.a058043","article-title":"Prolonged disease-free survival after high\u2013dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin\u2019s disease","volume":"2","author":"Gianni","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0125","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High dose therapy and ABMT after failure of conventional therapy in adults with intermediate grade or high grade non-Hodgkin\u2019s lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"NEJM"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1989.7.8.1039","article-title":"Allogeneic marrow transplantation for refractory Hodgkin\u2019s disease","volume":"7","author":"Phillips","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0135","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","article-title":"Evidence of a Graft versus lymphoma effect associated with allogeneic bone marrow transplantation","volume":"77","author":"Jones","year":"1991","journal-title":"Blood"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0140","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/blood.V74.4.1260.1260","article-title":"High dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma","volume":"74","author":"Kessinger","year":"1989","journal-title":"Blood"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0145","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1200\/JCO.1990.8.6.978","article-title":"Autologous blood stem cell transplantation in patients with advanced Hodgkin\u2019s disease and prior radiation to the pelvic site","volume":"8","author":"Korbling","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0150","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(89)90711-3","article-title":"Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation","volume":"2","author":"Gianni","year":"1989","journal-title":"Lancet"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hon.2900070205","article-title":"Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?","volume":"7","author":"Gianni","year":"1989","journal-title":"Hematol Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0160","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM198809083191001","article-title":"Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy induced myelosuppression","volume":"319","author":"Antman","year":"1989","journal-title":"N Eng J Med"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0165","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198804073181401","article-title":"Effect of recombinant human granulocyte-macrophage colony-stimulating factor on haemopoietic reconstitution after high dose chemotherapy and autologous bone marrow transplantation","volume":"318","author":"Brandt","year":"1988","journal-title":"N Eng J Med"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0170","first-page":"49","article-title":"GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation","volume":"4","author":"Devereux","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0175","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM199106203242504","article-title":"Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer","volume":"324","author":"Nemunaitis","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0180","first-page":"432","article-title":"Comparative effects of rHuG-CSF and rHuGM-CSF on haematopoietic reconstitution and granulocyte function following high dose chemotherapy and autologous bone marrow transplantation","volume":"72","author":"Peters","year":"1988","journal-title":"Blood"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0185","first-page":"452","article-title":"Phase II study of recombinant human granulocyte colony-stimulating factor in Hodgkin\u2019s disease after high dose chemotherapy with ABMT","volume":"72","author":"Taylor","year":"1988","journal-title":"Blood"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.1992.tb06424.x","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: A BNLI double-blind placebo\u2013controlled trial","volume":"82","author":"Khwaja","year":"1992","journal-title":"Brit J Haemat"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0195","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2141.1992.tb08222.x","article-title":"The effect of macrophage colony-stimulating factor on haemopoietic recovery after autologous bone marrow transplantation","volume":"81","author":"Khwaja","year":"1992","journal-title":"Brit J Haemat"},{"issue":"suppl 2","key":"10.1093\/annonc\/4.suppl_1.S21_bb0200","first-page":"52","article-title":"Radiotherapy for residual Hodgkin\u2019s disease after BEAM chemotherapy and autologous bone marrow transplantation","volume":"4","author":"McMillan","year":"1989","journal-title":"Brit J Haematol"},{"issue":"suppl 2","key":"10.1093\/annonc\/4.suppl_1.S21_bb0205","first-page":"195","article-title":"High dose chemotherapy and autologous bone marrow transplantation for Hodgkin\u2019s disease in Italy","volume":"5","author":"Carella","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0210","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.1990.8.4.648","article-title":"Cyclophosphamide, carmustine and etoposide with autologous bone marrow transplantation in refractory Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma: A dose finding study","volume":"8","author":"Wheeler","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0215","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/bjc.1989.128","article-title":"High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin\u2019s disease","volume":"59","author":"Zulian","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0220","article-title":"A randomised trial of BEAM and ABMT versus MiniBEAM in relapsed and resistant Hodgkin\u2019s disease","volume":"403","author":"Linch","year":"1992","journal-title":"European Bone Marrow Transplant Group"},{"key":"10.1093\/annonc\/4.suppl_1.S21_bb0225","series-title":"Autologous bone marrow transplantation-proceedings of the Fifth International Symposium","article-title":"Autologous bone marrow transplantation for Hodgkin\u2019s disease: Cooperative group trials in the United States","author":"Hurd","year":"1990"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341965012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341965012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/4\/suppl_1\/S21\/6678531\/4-suppl_1-S21.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T21:36:56Z","timestamp":1582234616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341965012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"references-count":45,"alternative-id":["S092375341965012X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/4.suppl_1.s21","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1993]]}}}